Depression may start with cells that can't handle stress

Researchers just found something unexpected about how depression works at the cellular level — and it could change how doctors diagnose and treat it early.

Scientists at the University of Queensland and University of Minnesota studied the energy-producing molecules in the brains and blood of young people with major depression. They were looking at ATP, basically the fuel that powers every cell in your body. What they found was counterintuitive: cells from people with depression actually produced more energy while resting, but couldn't ramp up production when stress hit.

"This suggests cells may be overworking early in the illness, which could lead to longer-term problems," says Dr. Roger Varela from the Queensland Brain Institute. Think of it like a car engine that's constantly revving at idle — it looks powerful until you need to accelerate, and then it stalls.

The team analyzed brain scans and blood samples from 18 people aged 18–25 with depression and compared them to people without it. The pattern was clear: in early depression, the mitochondria (the powerhouses inside cells) have a harder time meeting higher energy demands. That cellular exhaustion might explain why depression comes with such relentless fatigue, lack of motivation, and brain fog — symptoms that are notoriously hard to treat.

Why this matters

Fatigue in depression can take years to address because doctors haven't had a clear biological marker to point to. "There has been limited progress in developing new treatments because of a lack of research," says Associate Professor Susannah Tye, who led the study. This discovery opens a door: if you can measure ATP patterns in blood samples, you might catch depression earlier and match treatments to what's actually happening in a person's cells.

The research also hints at something important that clinicians are starting to accept more widely — depression isn't one disease. "Every patient has different biology, and each patient is impacted differently," Varela notes. One person's depression might stem from energy dysregulation; another's might involve different mechanisms entirely. That means the one-size-fits-all approach to antidepressants could eventually give way to more targeted interventions.

The next step is moving from this small study to larger ones that could validate these patterns and figure out whether measuring ATP could become a standard diagnostic tool. If it does, people might spend months instead of years finding the right treatment.

The study was published in Translational Psychiatry.